SMAD4 mosaicism in juvenile polyposis: Essential contribution of somatic analysis in diagnosis.
Sabine VautierJacques MauillonNathalie ParodiJacqueline BouEdwige KasperSandrine ManaseClaude HoudayerStéphanie Baert-DesurmontPublished in: American journal of medical genetics. Part A (2024)
Juvenile polyposis syndrome (JPS) is a rare disease characterized by multiple hamartomatous polyps in the gastrointestinal tract, associated with pathogenic variants of BMPR1A and SMAD4. We present the description of SMAD4 mosaicism in a 30-year-old man who had caecum adenocarcinoma, 11 juvenile colon polyps and epistaxis since childhood. We conducted NGS polyposis and CRC panel analysis on DNA extracted from two polyps, revealing a likely pathogenic SMAD4 variant: NM_005359.5:c. 1600C>T, p.(Gln534*). This variant was then identified at a very low frequency on blood and normal colonic tissue, by targeted visualization of previously obtained NGS data. These findings support the presence of a likely pathogenic mosaic SMAD4 variant that aligns with the patient's phenotype. Given the relatively frequent occurrence of de novo SMAD4 mutations, somatic mosaicism could account for a significant proportion of sporadic JPS patients with unidentified pathogenic variants. This case underscores the diagnosis challenge of detecting mosaicism and emphasizes the importance of somatic analyses.
Keyphrases
- epithelial mesenchymal transition
- transforming growth factor
- chronic rhinosinusitis
- copy number
- squamous cell carcinoma
- case report
- risk assessment
- signaling pathway
- dna methylation
- big data
- pulmonary hypertension
- drug delivery
- young adults
- radiation therapy
- cancer therapy
- circulating tumor
- amyotrophic lateral sclerosis
- genome wide
- data analysis
- artificial intelligence